Profil
Dr. David M.
Gravett is Vice President-Research & Development at Carbylan Therapeutics, Inc.
Dr. Gravett was previously employed as Vice President-Formulations & Polymer Chemistry by Angiotech Pharmaceuticals, Inc. and a Principal by Pasteur Mérieux Connaught.
He received his doctorate degree from the University of Toronto.
Anciens postes connus de David M. Gravett
| Sociétés | Poste | Fin |
|---|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Directeur Technique/Scientifique/R&D | 15/04/2016 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Corporate Officer/Principal | - |
Pasteur Mérieux Connaught | Corporate Officer/Principal | - |
Formation de David M. Gravett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
University of Natal
University of Natal Other Consumer ServicesConsumer Services College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pasteur Mérieux Connaught |
















